Soundwatch Capital LLC Buys New Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Soundwatch Capital LLC bought a new stake in UnitedHealth Group Incorporated (NYSE:UNH) in the second quarter, Holdings Channel reports. The institutional investor bought 1,709 shares of the healthcare conglomerate’s stock, valued at approximately $870,000. UnitedHealth Group accounts for approximately 4.8% of Soundwatch Capital LLC’s portfolio, making the stock its 7th largest holding.

A number of other large investors have also modified their holdings of the company. Macroview Investment Management LLC raised its stake in UnitedHealth Group by 671.4% during the second quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock worth $28,000 after acquiring an additional 47 shares in the last quarter. Delos Wealth Advisors LLC raised its stake in UnitedHealth Group by 757.1% during the first quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock worth $30,000 after acquiring an additional 53 shares in the last quarter. True Wealth Design LLC acquired a new position in UnitedHealth Group during the fourth quarter worth $31,000. Bbjs Financial Advisors LLC acquired a new position in UnitedHealth Group during the second quarter worth $31,000. Finally, Signature Resources Capital Management LLC raised its stake in UnitedHealth Group by 40.0% during the second quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate’s stock worth $32,000 after acquiring an additional 18 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at UnitedHealth Group

In related news, CAO Thomas E. Roos sold 2,851 shares of the business’s stock in a transaction that occurred on Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total value of $1,624,727.88. Following the completion of the transaction, the chief accounting officer now directly owns 29,501 shares in the company, valued at approximately $16,812,029.88. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,500 shares of the business’s stock in a transaction that occurred on Thursday, July 18th. The stock was sold at an average price of $579.03, for a total value of $868,545.00. Following the sale, the executive vice president now owns 7,785 shares in the company, valued at approximately $4,507,748.55. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, CAO Thomas E. Roos sold 2,851 shares of the company’s stock in a transaction that occurred on Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total value of $1,624,727.88. Following the sale, the chief accounting officer now owns 29,501 shares in the company, valued at approximately $16,812,029.88. The disclosure for this sale can be found here. 0.33% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

A number of analysts have recently weighed in on UNH shares. Baird R W upgraded UnitedHealth Group to a “strong-buy” rating in a research note on Thursday, May 30th. Royal Bank of Canada lifted their price target on UnitedHealth Group from $555.00 to $615.00 and gave the company an “outperform” rating in a report on Wednesday, July 17th. Robert W. Baird lifted their price target on UnitedHealth Group from $597.00 to $640.00 and gave the company an “outperform” rating in a report on Wednesday, July 17th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $591.00 price target on shares of UnitedHealth Group in a report on Monday. Finally, Morgan Stanley lifted their price target on UnitedHealth Group from $595.00 to $615.00 and gave the company an “overweight” rating in a report on Wednesday, July 17th. One analyst has rated the stock with a hold rating, nineteen have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Buy” and an average target price of $614.17.

UnitedHealth Group Price Performance

UnitedHealth Group stock opened at $580.32 on Thursday. The firm has a market capitalization of $535.88 billion, a P/E ratio of 35.47, a PEG ratio of 1.64 and a beta of 0.58. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $607.94. The business has a 50-day moving average of $574.38 and a 200-day moving average of $519.42. The company has a current ratio of 0.88, a quick ratio of 0.88 and a debt-to-equity ratio of 0.67.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.66 by $0.14. The company had revenue of $98.86 billion during the quarter, compared to analyst estimates of $98.73 billion. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The company’s revenue for the quarter was up 6.4% compared to the same quarter last year. During the same period in the previous year, the company earned $6.14 EPS. On average, equities analysts anticipate that UnitedHealth Group Incorporated will post 27.69 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 24th. Investors of record on Monday, September 16th will be given a $2.10 dividend. The ex-dividend date is Monday, September 16th. This represents a $8.40 annualized dividend and a dividend yield of 1.45%. UnitedHealth Group’s dividend payout ratio is presently 51.34%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.